Bioactive Risdiplam (Evrysdi, RG7916, RO7034067) is a modifier of SMN2 pre-mRNA splicing for oral administration, which can be distributed in the central nervous system (CNS) and surrounding tissues.
Contact: Emma Chen
Phone: +8618791163155
Tel: +8618791163155
Email: 18791163155@163.com
Add: Room 403,Building 8,West Life Science and Technology Park,Keyuan 4th Road,Xixian New District,Xi'an City,Shaanxi Province
We chat